Targeted Precise Quantification of 12 Human Recombinant Uridine-Diphosphate Glucuronosyl Transferase 1A and 2B Isoforms Using Nano-Ultra-High-Performance Liquid Chromatography/Tandem Mass Spectrometry with Selected Reaction Monitoring

被引:63
作者
Fallon, John K. [1 ]
Neubert, Hendrik [2 ]
Goosen, Theunis C.
Smith, Philip C. [1 ]
机构
[1] Univ N Carolina, Eshelman Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC 27599 USA
[2] Pfizer Inc, Dept Pharmacokinet Dynam & Metab, Andover, MA USA
基金
美国国家卫生研究院;
关键词
HUMAN UDP-GLUCURONOSYLTRANSFERASES; HUMAN LIVER; EXPRESSION; METABOLISM; PROTEOMICS;
D O I
10.1124/dmd.113.053801
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Quantification methods employing stable isotope-labeled peptide standards and liquid chromatography-tandem mass spectrometry are increasingly being used to measure enzyme amounts in biologic samples. Isoform concentrations, combined with catalytic information, can be used in absorption, distribution, metabolism, and excretion studies to improve accuracy of in vitro/in vivo predictions. We quantified isoforms of uridine-diphosphate glucuronosyltransferase (UGT) 1A and 2B in 12 commercially available recombinant UGTs (recUGTs) (n = 49 samples) using nano-ultra-high-performance liquid chromatography-tandem mass spectrometry with selected reaction monitoring). Samples were trypsin-digested and analyzed using our previously published method. Two MRMs were collected per peptide and averaged. Where available, at least two peptides were measured per UGT isoform. The assay could detect UGTs in all recombinant preparations: recUGTs 1A1, 1A3, 1A4, 1A6, 1A7, 1A8, 1A9, 1A10, 2B4, 2B7, 2B15, and 2B17, with limit of detection below 1.0 pmol/mg protein for all isoforms. The assay had excellent linearity in the range observed (2-15.5 pmol/mg, after dilution). Examples of concentrations determined were 1465, 537, 538, 944, 865, 698, 604, 791, 382, 1149, 307, and 740 pmol/mg protein for the respective isoforms. There was a 6.9-fold difference between the maximum and minimum recUGT concentrations. The range of concentrations determined indicates that catalytic rates per mg total protein in vitro will not accurately reflect isoform inherent specific activity for a particular drug candidate. This is the first report of a targeted precise quantification of commercially available recUGTs. The assay has potential for use in comparing UGT amounts with catalytic activity determined using probe substrates, thus allowing representation of catalysis as per pmol of UGT isoform.
引用
收藏
页码:2076 / 2080
页数:5
相关论文
共 13 条
  • [1] Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases
    Court, MH
    [J]. PHASE II CONJUGATION ENZYMES AND TRANSPORT SYSTEMS, 2005, 400 : 104 - 116
  • [2] Targeted Quantitative Proteomics for the Analysis of 14 UGT1As and-2Bs in Human Liver Using NanoUPLC-MS/MS with Selected Reaction Monitoring
    Fallon, John K.
    Neubert, Hendrik
    Hyland, Ruth
    Goosen, Theunis C.
    Smith, Philip C.
    [J]. JOURNAL OF PROTEOME RESEARCH, 2013, 12 (10) : 4402 - 4413
  • [3] Fallon John K, 2008, Drug Metab Lett, V2, P210, DOI 10.2174/187231208785425764
  • [4] Quantification of Human Uridine-Diphosphate Glucuronosyl Transferase 1A Isoforms in Liver, Intestine, and Kidney Using Nanobore Liquid Chromatography-Tandem Mass Spectrometry
    Harbourt, David E.
    Fallon, John K.
    Ito, Shinya
    Baba, Takashi
    Ritter, Joseph K.
    Glish, Gary L.
    Smith, Philip C.
    [J]. ANALYTICAL CHEMISTRY, 2012, 84 (01) : 98 - 105
  • [5] Absolute Difference of Hepatobiliary Transporter Multidrug Resistance-Associated Protein (MRP2/Mrp2) in Liver Tissues and Isolated Hepatocytes from Rat, Dog, Monkey, and Human
    Li, Na
    Zhang, Yiqun
    Hua, Fengmei
    Lai, Yurong
    [J]. DRUG METABOLISM AND DISPOSITION, 2009, 37 (01) : 66 - 73
  • [6] Simultaneous Absolute Protein Quantification of Transporters, Cytochromes P450, and UDP-Glucuronosyltransferases as a Novel Approach for the Characterization of Individual Human Liver: Comparison with mRNA Levels and Activities
    Ohtsuki, Sumio
    Schaefer, Olaf
    Kawakami, Hirotaka
    Inoue, Tae
    Liehner, Stephanie
    Saito, Asami
    Ishiguro, Naoki
    Kishimoto, Wataru
    Ludwig-Schwellinger, Eva
    Ebner, Thomas
    Terasaki, Tetsuya
    [J]. DRUG METABOLISM AND DISPOSITION, 2012, 40 (01) : 83 - 92
  • [7] Immunochemical identification of UGT isoforms in human small bowel and in Caco-2 cell monolayers
    Paine, MF
    Fisher, MB
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 273 (03) : 1053 - 1057
  • [8] Proteomics meets the scientific method
    Picotti, Paola
    Bodenmiller, Bernd
    Aebersold, Ruedi
    [J]. NATURE METHODS, 2013, 10 (01) : 24 - 27
  • [9] Expression and inducibility of the human bilirubin UDP-glucuronosyltransferase UGTLA1 in liver and cultured primary hepatocytes: Evidence for both genetic and environmental influences
    Ritter, JK
    Kessler, FK
    Thompson, ET
    Grove, AD
    Auyeung, DJ
    Fisher, RA
    [J]. HEPATOLOGY, 1999, 30 (02) : 476 - 484
  • [10] The UDP-glucuronosyltransferases: Their role in drug metabolism and detoxification
    Rowland, Andrew
    Miners, John O.
    Mackenzie, Peter I.
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2013, 45 (06) : 1121 - 1132